Expert Consensus on Nutritional Management for Patients with Amyotrophic Lateral Sclerosis

doi:10.3969/j.issn.1673-5765.2025.02.012

Abstract

Abstract: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. Proper nutritional management is of great significance in delaying disease progression and improving the quality of life for ALS patients. Based on existing clinical guidelines and research literature, the Working Group of Motor Neuron Disease of National Center for Medical Quality Control of Nervous System Diseases formed an expert consensus on the nutritional management of ALS patients using the Delphi method. This consensus deeply discusses the important issues in the nutritional management of ALS patients, such as multidisciplinary collaboration, nutritional intervention goals, dysphagia assessment, methods of nutritional support, and social support, and proposes seven specific recommendations and implementation strategies. The consensus emphasizes the individualization of nutritional management for ALS patients and dynamic adjustment of nutritional strategy according to the progression of the disease. Through scientific clinical assessment and intervention, the nutritional status of patients can be improved, thereby improving the quality of life and delaying disease progression.

Key words: Amyotrophic lateral sclerosis; Motor neuron disease; Nutritional management; Malnutrition; Dysphagia

摘要： 肌萎缩侧索硬化（amyotrophic lateral sclerosis，ALS）是一种致死性的神经退行性疾病。恰当的营养管理对延缓ALS的疾病进展、提高患者的生活质量意义重大。国家神经系统疾病医疗质量控制中心运动神经元病工作组基于现有的临床指南、研究文献，通过德尔菲法组织形成了针对ALS患者营养管理的专家共识。本专家共识针对ALS患者营养管理的重要问题，如多学科协作、营养干预目标、吞咽困难评估、营养支持方式及社会支持等，进行了深入探讨，并提出了7项具体建议和实施策略。专家共识强调ALS患者营养管理的个体化，以及根据患者病程进展进行动态调整的营养策略。通过科学的临床评估和干预，改善患者的营养状态，从而提高患者的生存质量，延缓疾病进展。

关键词: 肌萎缩侧索硬化; 运动神经元病; 营养管理; 营养不良; 吞咽困难

CLC Number:

Working Group of Motor Neuron Disease of National Center for Medical Quality Control of Nervous System Diseases, National Center for Medical Quality Control of Nervous System Diseases. Expert Consensus on Nutritional Management for Patients with Amyotrophic Lateral Sclerosis[J]. Chinese Journal of Stroke, 2025, 20(2): 218-227.

国家神经系统疾病医疗质量控制中心运动神经元病工作组, 国家神经系统疾病医疗质量控制中心. 肌萎缩侧索硬化患者营养管理专家共识[J]. 中国卒中杂志, 2025, 20(2): 218-227.

References

[1] BROWN R H，AL-CHALABI A. Amyotrophic lateral sclerosis[J]. N Engl J Med，2017，377（2）：162-172.
[2] WOLFSON C，GAUVIN D E，ISHOLA F，et al. Global prevalence and incidence of amyotrophic lateral sclerosis：a systematic review[J/OL]. Neurology，2023，101（6）：e613-e623[2024-12-20]. https://doi.org/10.1212/WNL.0000000000207474.
[3] XU L，LIU T X，LIU L L，et al. Global variation in prevalence and incidence of amyotrophic lateral sclerosis：a systematic review and meta-analysis[J]. J Neurol，2020，267（4）：944-953.
[4] ZARCO-MARTÍN M T，FREIRE C，ANDREO-LÓPEZ M C，et al. Malnutrition in amyotrophic lateral sclerosis：insights from morphofunctional assessment and global leadership initiative on malnutrition criteria[J/OL]. Nutrients，2024，16（16）：2625[2024-12-20]. https://doi.org/10.3390/nu16162625.
[5] LÓPEZ-GÓMEZ J J，BALLESTEROS-POMAR M D，TORRES-TORRES B，et al. Malnutrition at diagnosis in amyotrophic lateral sclerosis（ALS）and its influence on survival：using glim criteria[J]. Clin Nutr，2021，40（1）：237-244.
[6] LUDOLPH A，DUPUIS L，KASARSKIS E，et al. Nutritional and metabolic factors in amyotrophic lateral sclerosis[J]. Nat Rev Neurol，2023，19（9）：511-524.
[7] 中华医学会神经病学分会肌萎缩侧索硬化协作组. 肌萎缩侧索硬化诊断和治疗中国专家共识2022[J]. 中华神经科杂志，2022，55（6）：581-588.
Amyotrophic Lateral Sclerosis Collaboration Group of Chinese Society of Neurology. Consensus for diagnosis and treatment of amyotrophic lateral sclerosis 2022[J]. Chin J Neurol，2022，55（6）：581-588.
[8] 何及，樊东升. 建立中国运动神经元病医疗规范和持续质量改进体系[J]. 中国卒中杂志，2024，19（1）：66-68.
HE J，FAN D S. Establish a medical standard and continuous quality improvement system for motor neuron disease in China[J]. Chin J Stroke，2024，19（1）：66-68.
[9] VAN DAMME P，AL-CHALABI A，ANDERSEN P M，et al. European Academy of Neurology（EAN）guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases（ERN EURO-NMD）[J/OL]. Eur J Neurol，2024，31（6）：e16264[2024-12-20]. https://doi.org/10.1111/ene.16264.
[10] BARROS A N A B，FELIPE M L D N，BARBOSA I R，et al. Dietary intake of micronutrients and disease severity in patients with amyotrophic lateral sclerosis[J/OL]. Metabolites，2023，13（6）：696[2024-12-20]. https://doi.org/10.3390/metabo13060696.
[11] HOGDEN A，FOLEY G，HENDERSON R D，et al. Amyotrophic lateral sclerosis：improving care with a multidisciplinary approach[J/OL]. J Multidiscip Healthc，2017，10：205-215[2024-12-20]. https://doi.org/10.2147/JMDH.S134992.
[12] KÖRNER S，HENDRICKS M，KOLLEWE K，et al. Weight loss，dysphagia and supplement intake in patients with amyotrophic lateral sclerosis（ALS）：impact on quality of life and therapeutic options[J/OL]. BMC Neurol，2013，13：84[2024-12-20]. https://doi.org/10.1186/1471-2377-13-84.
[13] WEI Q Q，OU R W，CAO B，et al. Early weight instability is associated with cognitive decline and poor survival in amyotrophic lateral sclerosis[J/OL]. Brain Res Bull，2021，171：10-15[2024-12-20]. https://doi.org/10.1016/j.brainresbull.2021.02.022.
[14] JANSE VAN MANTGEM M R，VAN EIJK R P A，VAN DER BURGH H K，et al. Prognostic value of weight loss in patients with amyotrophic lateral sclerosis：a population-based study[J]. J Neurol Neurosurg Psychiatry，2020，91（8）：867-875.
[15] HÉRITIER A C，JANSSENS J P，ADLER D，et al. Should patients with ALS gain weight during their follow-up？[J]. Nutrition，2015，31（11/12）：1368-1371.
[16] YANG L P，FAN D S. Diets for patients with amyotrophic lateral sclerosis：pay attention to nutritional intervention[J]. Chin Med J（Engl），2017，130（15）：1765-1767.
[17] MUSCARITOLI M，KUSHTA I，MOLFINO A，et al. Nutritional and metabolic support in patients with amyotrophic lateral sclerosis[J]. Nutrition，2012，28（10）：959-966.
[18] WAHEED W，KHAN F，NAUD S，et al. Urine specific gravity to identify and predict hydration need in ALS[J]. Amyotroph Lateral Scler Frontotemporal Degener，2022，23（5/6）：407-414.
[19] REBER E，GOMES F，DÄHN I A，et al. Management of dehydration in patients suffering swallowing difficulties[J/OL]. J Clin Med，2019，8（11）：1923[2024-12-20]. https://doi.org/10.3390/jcm8111923.
[20] LEE J，MADHAVAN A，KRAJEWSKI E，et al. Assessment of dysarthria and dysphagia in patients with amyotrophic lateral sclerosis：review of the current evidence[J]. Muscle Nerve，2021，64（5）：520-531.
[21] REBER E，GOMES F，VASILOGLOU M F，et al. Nutritional risk screening and assessment[J/OL]. J Clin Med，2019，8（7）：1065[2024-12-20]. https://doi.org/10.3390/jcm8071065.
[22] STÖRCHLE P，MÜLLER W，SENGEIS M，et al. Measurement of mean subcutaneous fat thickness：eight standardised ultrasound sites compared to 216 randomly selected sites[J/OL]. Sci Rep，2018，8（1）：16268[2024-12-20]. https://doi.org/10.1038/s41598-018-34213-0.
[23] GALLO V，WARK P A，JENAB M，et al. Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis：the EPIC cohort[J]. Neurology，2013，80（9）：829-838.
[24] PICÓ C，SERRA F，RODRÍGUEZ A M，et al. Biomarkers of nutrition and health：new tools for new approaches[J/OL]. Nutrients，2019，11（5）：1092[2024-12-20]. https://doi.org/10.3390/nu11051092.
[25] PENG H，CHEN B B，TANG L L，et al. Prognostic value of nutritional risk screening 2002 scale in nasopharyngeal carcinoma：a large-scale cohort study[J]. Cancer Sci，2018，109（6）：1909-1919.
[26] WANG Y J，YE S，CHEN L，et al. Loss of appetite in patients with amyotrophic lateral sclerosis is associated with weight loss and anxiety/depression[J/OL]. Sci Rep，2021，11（1）：9119[2024-12-20]. https://doi.org/10.1038/s41598-021-88755-x.
[27] HOLM T，MAIER A，WICKS P，et al. Severe loss of appetite in amyotrophic lateral sclerosis patients：online self-assessment study[J/OL]. Interact J Med Res，2013，2（1）：e8[2024-12-20]. https://doi.org/10.2196/ijmr.2463.
[28] CARVALHO T L，DE ALMEIDA L M，LOREGA C M，et al. Depression and anxiety in individuals with amyotrophic lateral sclerosis：a systematic review[J/OL]. Trends Psychiatry Psychother，2016，38（1）：1-5[2024-12-20]. https://doi.org/10.1590/2237-6089-2015-0030.
[29] 国家神经系统疾病医疗质量控制中心运动神经元病质控专病组. 肌萎缩侧索硬化医疗质量控制指标[J]. 中国卒中杂志，2024，19（1）：69-75.
The Motor Neuron Disease Working Group of National Center for Healthcare Quality Management in Neurological Diseases. Medical quality control indicators for amyotrophic lateral sclerosis[J]. Chin J Stroke，2024，19（1）：69-75.
[30] MARINO C，GRIMALDI M，SOMMELLA E M，et al. The metabolomic profile in amyotrophic lateral sclerosis changes according to the progression of the disease：an exploratory study[J/OL]. Metabolites，2022，12（9）：837[2024-12-20]. https://doi.org/10.3390/metabo12090837.
[31] HOLDOM C J，JANSE VAN MANTGEM M R，HE J，et al. Variation in resting metabolic rate affects identification of metabolic change in geographically distinct cohorts of patients with ALS[J/OL]. Neurology，2024，102（5）：e208117[2024-12-20]. https://doi.org/10.1212/WNL.0000000000208117.
[32] 林隽羽，欧汝威，商慧芳. 肌萎缩侧索硬化和糖尿病相关性研究进展[J]. 中国神经精神疾病杂志，2020，46（3）：175-178.
LIN J Y，OU R W，SHANG H F. Research progress on the correlation between amyotrophic lateral sclerosis and diabetes[J]. Chinese Journal of Nervous and Mental Diseases，2020，46（3）：175-178.
[33] MARIOSA D，KAMEL F，BELLOCCO R，et al. Antidiabetics，statins and the risk of amyotrophic lateral sclerosis[J]. Eur J Neurol，2020，27（6）：1010-1016.
[34] HU N，JI H Y. Medications on hypertension，hyperlipidemia，diabetes，and risk of amyotrophic lateral sclerosis：a systematic review and meta-analysis[J]. Neurol Sci，2022，43（9）：5189-5199.
[35] BURGOS R，BRETÓN I，CEREDA E，et al. ESPEN guideline clinical nutrition in neurology[J]. Clin Nutr，2018，37（1）：354-396.
[36] NAKAMURA R，KURIHARA M，KOBASHI S，et al. Ideal body weight-based determination of minimum oral calories beneficial to function and survival in ALS[J/OL]. Front Neurol，2023，14：1286153[2024-12-20]. https://doi.org/10.3389/fneur.2023.1286153.
[37] ESSAT M，COATES E，CLOWES M，et al. Understanding the current nutritional management for people with amyotrophic lateral sclerosis—a mapping review[J/OL]. Clin Nutr ESPEN，2022，49：328-340[2024-12-20]. https://doi.org/10.1016/j.clnesp.2022.03.026.
[38] D’AMICO E，GROSSO G，NIEVES J W，et al. Metabolic abnormalities，dietary risk factors and nutritional management in amyotrophic lateral sclerosis[J/OL]. Nutrients，2021，13（7）：2273[2024-12-20]. https://doi.org/10.3390/nu13072273.
[39] MARTENS E A，LEMMENS S G，WESTERTERP-PLANTENGA M S. Protein leverage affects energy intake of high-protein diets in humans[J]. Am J Clin Nutr，2013，97（1）：86-93.
[40] SUN J，ZHANG Y G. Microbiome and micronutrient in ALS：from novel mechanisms to new treatments[J/OL]. Neurotherapeutics，2024，21（6）：e00441[2024-12-20]. https://doi.org/10.1016/j.neurot.2024.e00441.
[41] PRELL T，GROSSKREUTZ J，Pooled Resource Open-Access ALS Clinical Trials Consortium. Use of vitamins by participants in amyotrophic lateral sclerosis clinical trials[J/OL]. PLoS One，2020，15（8）：e0237175[2024-12-20]. https://doi.org/10.1371/journal.pone.0237175.
[42] ICER M A，ARSLAN N，GEZMEN-KARADAG M. Effects of vitamin E on neurodegenerative diseases：an update[J]. Acta Neurobiol Exp（Wars），2021，81（1）：21-33.
[43] 中国吞咽障碍康复评估与治疗专家共识组. 中国吞咽障碍评估与治疗专家共识（2017年版）第二部分治疗与康复管理篇[J]. 中华物理医学与康复杂志，2018，40（1）：1-10.
Expert Consensus Group on Rehabilitation Assessment and Treatment of Dysphagia in China. Expert consensus on the assessment and treatment of dysphagia in China（2017 edition）. Part Ⅱ treatment and rehabilitation management[J]. Chin J Phys Med Rehabil，2018，40（1）：1-10.
[44] XIA X Q，ZHANG W，GUO J H，et al. Diagnostic utility of different dysphagia screening tools to detect dysphagia in individuals with amyotrophic lateral sclerosis[J]. Neurol Sci，2023，44（11）：3919-3927.
[45] HELLIWELL K，HUGHES V J，BENNION C M，et al. The use of videofluoroscopy（VFS）and fibreoptic endoscopic evaluation of swallowing（FEES）in the investigation of oropharyngeal dysphagia in stroke patients：a narrative review[J]. Radiography（Lond），2023，29（2）：284-290.
[46] RUOPPOLO G，SCHETTINO I，FRASCA V，et al. Dysphagia in amyotrophic lateral sclerosis：prevalence and clinical findings[J]. Acta Neurol Scand，2013，128（6）：397-401.
[47] 中国吞咽障碍膳食营养管理专家共识组. 吞咽障碍膳食营养管理中国专家共识（2019版）[J]. 中华物理医学与康复杂志，2019，41（12）：881-888.
Expert Consensus Group on Dietary Nutritional Management of Dysphagia in China. Chinese expert consensus on dietary nutritional management of dysphagia in China（2019 edition）[J]. Chin J Phys Med Rehabil，2019，41（12）：881-888.
[48] 中华医学会肠外肠内营养学分会. 成人口服营养补充专家共识[J]. 中华胃肠外科杂志，2017，20（4）：361-365.
Chinese Society of Parenteral and Enteral Nutrition. Expert consensus on oral nutritional supplement for adults[J]. Chin J Gastrointest Surg，2017，20（4）：361-365.
[49] SHOESMITH C，ABRAHAO A，BENSTEAD T，et al. Canadian best practice recommendations for the management of amyotrophic lateral sclerosis[J/OL]. CMAJ，2020，192（46）：E1453-E1468[2024-12-20]. https://doi.org/10.1503/cmaj.191721.
[50] 中华医学会消化内镜学分会老年内镜协作组，北京医学会消化内镜学分会. 老年人经皮内镜下胃造瘘术中国专家共识（2022版）[J]. 中华消化内镜杂志，2023，40（2）：85-93.
Geriatric Endoscopy Cooperative Group of Chinese Society of Digestive Endoscopology，Digestive Endoscopy Branch of Beijing Medical Association. Consensus of Chinese experts on percutaneous endoscopic gastrostomy in geriatric populations（2022）[J]. Chin J Dig Endosc，2023，40（2）：85-93.
[51] SCHÖRGHUBER M，FRUHWALD S. Effects of enteral nutrition on gastrointestinal function in patients who are critically ill[J]. Lancet Gastroenterol Hepatol，2018，3（4）：281-287.
[52] OH J，KIM J A. Supportive care needs of patients with amyotrophic lateral sclerosis/motor neuron disease and their caregivers：a scoping review[J]. J Clin Nurs，2017，26（23/24）：4129-4152.
[53] FOLEY G，HYNES G. Decision-making among patients and their family in ALS care：a review[J]. Amyotroph Lateral Scler Frontotemporal Degener，2018，19（3/4）：173-193.
[54] HALLIDAY V，ZAROTTI N，COATES E，et al. Delivery of nutritional management services to people with amyotrophic lateral sclerosis（ALS）[J]. Amyotroph Lateral Scler Frontotemporal Degener，2021，22（5/6）：350-359.